Percutaneous coronary intervention in patients with multi-vessel coronary artery disease: a focus on physiology
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Multi-vessel coronary artery disease (MVD) frequently features ambiguous or intermediate lesions that may be both serial and complex, suggesting that multiple regions require revascularization. Percutaneous coronary intervention (PCI) is associated with various challenges such as appropriate identification of lesions that should be treated, the choice of an optimum revascularization method, and limitations of long-term outcomes. Optimal patient selection and careful targeting of lesions are key when planning treatment. Physiology-guided decision-making (based on the fractional flow reserve) can overcome the current limitations of PCI used to treat MVD regardless of clinical presentation or disease subtype, as confirmed in recent clinical trials. Here, we review the use of physiology-guided PCI for patients with MVD, and their early and late outcomes.
Abstract
Multi-vessel coronary artery disease (MVD) frequently features ambiguous or intermediate lesions that may be both serial and complex, suggesting that multiple regions require revascularization. Percutaneous coronary intervention (PCI) is associated with various challenges such as appropriate identification of lesions that should be treated, the choice of an optimum revascularization method, and limitations of long-term outcomes. Optimal patient selection and careful targeting of lesions are key when planning treatment. Physiology-guided decision-making (based on the fractional flow reserve) can overcome the current limitations of PCI used to treat MVD regardless of clinical presentation or disease subtype, as confirmed in recent clinical trials. Here, we review the use of physiology-guided PCI for patients with MVD, and their early and late outcomes.
참고문헌 (31)
- Mabin TA, "Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty", Circulation, 71, pp.754~760 (1985)[DOI]
- Corpus RA, "Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction", Am Heart J, 148, pp.493~500 (2004)[DOI]
- Min JK, "Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality", J Am Coll Cardiol, 50, pp.1161~1170 (2007)[DOI]
- Tonino PA, "Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation", J Am Coll Cardiol, 55, pp.2816~2821 (2010)[DOI]
- Levine GN, "2011 ACCF", AHA, American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions, pp.J Am Coll Cardiol, 2011[DOI]
- Authors, "Task Force members", 2014 ESC, Eur Heart J, pp.2014, 35[DOI]
- Bypass Angioplasty Revascularization Investigation (BARI) Investigators, "Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease", N Engl J Med, 335, pp.217~225 (1996)[DOI]
- BARI Investigators, "The final 10-year follow-up results from the BARI randomized trial", J Am Coll Cardiol, 49, pp.1600~1606 (2007)[DOI]
- Serruys PW, "Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease", N Engl J Med, 344, pp.1117~1124 (2001)[DOI]
- Serruys PW, "Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial", J Am Coll Cardiol, 46, pp.575~581 (2005)[DOI]
- Serruys PW, "Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease", N Engl J Med, 360, pp.961~972 (2009)[DOI]
- Head SJ, "Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial", Eur Heart J, 35, pp.2821~2830 (2014)[DOI]
- Park SJ, "Trial of everolimus-eluting stents or bypass surgery for coronary disease", N Engl J Med, 372, pp.1204~1212 (2015)[DOI]
- Gersh BJ, "Methods of coronary revascularization: things may not be as they seem", N Engl J Med, 352, pp.2235~2237 (2005)[DOI]
- Cho YK, "Usefulness of combined intravascular ultrasound parameters to predict functional significance of coronary artery stenosis and determinants of mismatch", EuroIntervention, 11, pp.163~170 (2015)[DOI]
- Melikian N, "Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease", JACC Cardiovasc Interv, 3, pp.307~314 (2010)[DOI]
- Tonino PA, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention", N Engl J Med, 360, pp.213~224 (2009)[DOI]
- Pijls NH, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study", J Am Coll Cardiol, 56, pp.177~184 (2010)[DOI]
- van Nunen LX, "Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial", Lancet, 386, pp.1853~1860 (2015)[DOI]
- Fearon WF, "Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease", Circulation, 122, pp.2545~2550 (2010)[DOI]
- Nam CW, "Functional SYNTAX score for risk assessment in multivessel coronary artery disease", J Am Coll Cardiol, 58, pp.1211~1218 (2011)[DOI]
- Nam CW, "Role of the functional SYNTAX score in evaluating multivessel coronary artery disease", Interv Cardiol, 3, pp.695~704 (2011)[DOI]
- Farooq V, "Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score", Circulation, 128, pp.141~151 (2013)[DOI]
- Choi KH, "TCT-333 Prognostic implication of functional incomplete revascularization and residual functional SYNTAX score in patients with coronary artery disease", J Am Coll Cardiol, 70(18 Suppl), pp.B137~ (2017)
- Ahn JM, "Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease: patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST trials", JACC Cardiovasc Interv, 10, pp.1415~1424 (2017)[DOI]
- Kobayashi Y, "The prognostic value of residual coronary stenoses after functionally complete revascularization", J Am Coll Cardiol, 67, pp.1701~1711 (2016)
- Tamita K, "Effects of microvascular dysfunction on myocardial fractional flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction", Catheter Cardiovasc Interv, 57, pp.452~459 (2002)[DOI]
- Layland J, "Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial", Eur Heart J, 36, pp.100~111 (2015)[DOI]
- Ntalianis A, "Fractional flow reserve for the assessment of nonculprit coronary artery stenosis in patients with acute myocardial infarction", JACC Cardiovasc Interv, 3, pp.1274~1281 (2010)[DOI]
- Engstrom T, "Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomized controlled trial", Lancet, 386, pp.665~671 (2015)[DOI]
- Smits PC, "Fractional flow reserve-guided multivessel angioplasty in myocardial infarction", N Engl J Med, 376, pp.1234~1244 (2017)[DOI]
